Article citationsMore>>

Nwegbu, M.M., Isa, H.A., Nwankwo, B.B., Okeke, C.C., Edet-Offong, U.J., Akinola, N.O., et al. (2017) Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCANTM) in Screening for Sickle Cell Disease. Hemoglobin, 41, 77-82.
https://doi.org/10.1080/03630269.2017.1329151

has been cited by the following article:

• TITLE: Systematic Screening of Neonatal Sickle Cell Disease with HemoTypeSCTM Kit-Test: Case Study and Literature Review

  AUTHORS: Emmanuel Tebandite Kasai, François Boemer, Roland Marini Djang’eing’a, Justin Kadima Ntokumunda, Salomon Batina Agasa, Nestor Ngbonda Dauly, Jean Pierre Alworong’a Opara

  KEYWORDS: Sickle Cell Disease, Hemoglobin Phenotype, HemoTypeSC™, Neonates

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.10 No.1, March 2, 2020

  ABSTRACT: emoTypeSC™ test is a new cheap, faster, and appropriate screening method for neonatal diagnosis of sickle cell disease. The literature reports a few cases of its applicability. This study extends the cases study and reviews the available literature. The sample consisted of 99 subjects, including 87 newborns (36 girls and 51 boys; 1.9 - 4.9 kg BW) sampled among 566 babies bone at six hospitals in Kisangani city (Democratic Republic of Congo) during March-April 2019; height infant-adolescents (